Literature DB >> 19309567

Analysis of memory and effector CD8+ T cell subsets in chronic graft-versus-host disease.

M D' Asaro1, A Salerno, F Dieli, N Caccamo.   

Abstract

In humans, the selective depletion of CD8+ cells may prevent GVHD after allogeneic transplantation. These cells can infiltrate and damage target tissues. It is of interest to investigate the phenotypical characteristics and cytotoxic properties of the different CD8+ subsets in cGVHD patients. In a preliminary study we found that patients with cGVHD had a markedly elevated percentage of peripheral blood CCR7-/CD45RA+ cells compared to patients without cGVHD; conversely, the CCR7+/CD45RA+ subsets of CD8+ cells was significantly decreased. In this study, we report in depth on the phenotype of effector T cell subsets in cGVHD patients, as well as their proliferative capability, cytotoxic properties and cellular turnover. We confirm a predominance of effector T cell subsets in cGVHD patients and show that a large fraction of these cells down-regulate CCR7 and re-express CD45RA, thus approaching end-stage differentiation. Moreover CD8+ cells of cGVHD patients have low CD8 coreceptor expression, reduced proliferative potential and a high content of perforin and granzyme A. They also have a lower cell turnover and have more propensity to apoptosis, as demonstrated by BrdU incorporation. Taken together, our findings indicate a perturbation of the balance between naive/memory and effector/CD45RA+ CD8+ T cells, and suggest an involvement of the latter compartment characterized by a high content of cytotoxic equipment, in the pathogenesis of cGVHD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19309567     DOI: 10.1177/039463200902200122

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  5 in total

1.  Increased Th17/Treg ratio in chronic liver GVHD.

Authors:  F Malard; C Bossard; E Brissot; P Chevallier; T Guillaume; J Delaunay; J-F Mosnier; P Moreau; M Grégoire; B Gaugler; M Mohty
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

2.  Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease.

Authors:  Bryan M Grogan; Laura Tabellini; Barry Storer; Tara E Bumgarner; Claudia C Astigarraga; Mary E D Flowers; Stephanie J Lee; Paul J Martin; Edus H Warren; John A Hansen
Journal:  Biol Blood Marrow Transplant       Date:  2011-03-24       Impact factor: 5.742

Review 3.  Biomarkers in chronic graft-versus-host disease.

Authors:  Jacob Rozmus; Kirk R Schultz
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

4.  Graft versus host disease following liver transplantation: A case report.

Authors:  Changsong Zhang; Guangshun Yang; Yang Ling; Guihua Chen; Tianbao Zhou
Journal:  Exp Ther Med       Date:  2014-07-17       Impact factor: 2.447

5.  Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization study.

Authors:  Huahua Zhong; Kexin Jiao; Xiao Huan; Rui Zhao; Manqiqige Su; Li-Ying Goh; Xueying Zheng; Zhirui Zhou; Sushan Luo; Chongbo Zhao
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.